Filter By:

Journal Check one or more journals to show results from those journals only.

Choose more journals

Article type Check one or more article types to show results from those article types only.
Subject Check one or more subjects to show results from those subjects only.
Date Choose a date option to show results from those dates only.

Custom date range

Clear all filters
Sort by:
Showing 1–7 of 7 results
Advanced filters: Author: Mary-Ann Fitzcharles Clear advanced filters
  • Opioids provide some modest pain relief for patients with rheumatoid arthritis, but prescription of these drugs is influenced by their association with risks for the individual and for society. Is denial of a treatment, even if that treatment is imperfect, justified when patients experience considerable pain and other treatment options are limited?

    • Winfried Häuser
    • Mary-Ann Fitzcharles
    News & Views
    Nature Reviews Rheumatology
    Volume: 13, P: 521-522
  • Opioids are increasingly used for the treatment of chronic noncancer pain, but this practice remains controversial. A new set of clinical recommendations attempts to guide clinicians through the issues.

    • Mary-Ann Fitzcharles
    • Yoram Shir
    News & Views
    Nature Reviews Rheumatology
    Volume: 5, P: 242-244
  • Fibromyalgia remains a challenge for researchers and clinicians. Three studies published in 2025 shed light on mechanisms and management by implicating gut microbiota in symptom perpetuation, demonstrating the potential of home-based neuromodulation, and examining the uncertain role of low-dose naltrexone.

    • Hance Clarke
    • Mary-Ann Fitzcharles
    News & Views
    Nature Reviews Rheumatology
    Volume: 22, P: 84-85
  • Fibromyalgia is characterized by chronic widespread pain, unrefreshing sleep, physical exhaustion and cognitive difficulties. The definition, pathogenesis and treatment of fibromyalgia are controversial, with some physicians contesting its existence. In this Primer, Häuser et al. explain these controversies.

    • Winfried Häuser
    • Jacob Ablin
    • Brian Walitt
    Reviews
    Nature Reviews Disease Primers
    Volume: 1, P: 1-16